Congress 2022 highlights

News from the 90th EAS Congress, Milan Italy: Tuesday 24th May, 2022 Lipoprotein(a) was in the spotlight in two key presentations in this session. Is lipoprotein(a) prothrombotic?This question is highly pertinent given that the apo(a) component of Lp(a) is structurally similar to plasminogen, and also is a competitor in vitro for binding sites resulting in … Read more

News from the 90th EAS Congress, Milan Italy  Science cannot provide all the answers to improving our health: we also need to be proactive in targeting our environment. According to the World Health Organization, in 2016, about one-quarter of all deaths worldwide were attributable to the environment.1 Understanding how much of this burden of disease … Read more

News from the 90th EAS Congress, Milan Italy: Monday 23rd May, 2022 Global risk estimation is fundamental to preventive cardiology, enabling clinicians to prioritise treatment to those at highest risk. However, as discussed by Professor Ian Graham (Co-Chair of the ESC Cardiovascular Risk Collaboration, Trinity College, Dublin), current approaches to global risk estimation are not … Read more

After 3 long years, the EAS Congress is up and running as a hybrid meeting with over 2300 delegates, nearly 1400 onsite. The next 3 days will highlight the latest news from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), key collaborative sessions with the European Society of Cardiology, International Atherosclerosis Society, the US National Lipid … Read more

News from the 90th EAS Congress, Milan Italy: Monday 23rd May, 2022 The Monday Late Breaker session reported first in-human data with a novel monoclonal antibody targeting the angiopoietin-like protein (ANGPTL) 3/8 complex.1 ANGPTL 3, 4, and, most recently, 8 are well-characterised protein inhibitors of lipoprotein lipase, a critical regulator of triglyceride metabolism. ANGPTL8 is … Read more

News from the 90th EAS Congress, Milan Italy: Tuesday 24th May, 2022 Apolipoprotein (apo) B: a friend or foe? This was the thought-provoking title of the opening lecture, presented by Dr Jan Albert Kuivenhoven (University Medical Center Groningen, University of Groningen, the Netherlands). ApoB is a key constituent of very low-density lipoproteins (VLDL), intermediate-density lipoproteins, … Read more

News from the 90th EAS Congress, Milan Italy: Monday 23rd May, 2022 The latest developments in personalised approaches to atherosclerotic cardiovascular disease (ASCVD) prevention were the focus of Plenary 1. Dr Chiara Giannarelli (Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Center at NYU Langone NYU Grossman School of Medicine, New York, USA) … Read more

News from the 90th EAS Congress, Milan Italy: Monday 23rd May, 2022 Familial hypercholesterolaemia (FH) is a common inherited metabolic disorder, affecting about one in 300 people.1 This means that in Europe, there are over half a million children and over 2 million adults with FH. Because these people have elevated plasma levels of low-density … Read more